Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Alitretinoin, ATC D11AH04

This is not an open procedure, but a so-called open-house model! The form for the open procedure is only used because no form exists for the open-house model. Contracts concluded under the open-house model do not fall under public procurement law due to the lack of a selection decision. The use of this form is not subject to public procurement regulations. AOK Bayern intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies for the active substance Alitretinoin, ATC D11AH04 pursuant to § 130a para. 8 SGB V. AOK Bayern offers all interested pharmaceutical companies that meet the eligibility criteria listed below the opportunity to conclude identical and non-individually negotiable discount agreements. The earliest possible start date for the contract is 01.06.2026; all contracts end on 31.05.2028. A contract may be concluded at any time during this period, but no later than 03.04.2028. The contracts may be terminated with one month's notice to the end of the month. If a rebate contract for medicines with the subject matter of the contract comes into force through a nationwide or state-specific open procedure, the open-house agreements will automatically cease to apply for the corresponding term. A contract will be concluded with all interested pharmaceutical companies that demonstrate their eligibility through a completed and signed self-declaration of reliability. The pharmaceutical company must submit the completed and signed contract (the representative authority of the signatory must be evident from the commercial register extract; otherwise, a power of attorney must be submitted) together with the completed and signed annex "Specification of the contract medicines" and the completed and signed self-declaration of reliability. The documents can be submitted either in WRITTEN FORM by hand-signed or ELECTRONICALLY with a qualified electronic signature. Hand-signed documents in WRITTEN FORM must be sent in duplicate original to the following address: AOK Bayern - Die Gesundheitskasse Vergabestelle SGB V ZE25 open-house Rabattverträge Carl-Wery-Str. 28 81739 München ELECTRONIC documents with a qualified electronic signature must be submitted via the communication section in the tender portal www.dtvp.de. If complete and correct documents are received by the 3rd of each month, the contract will commence on the first of the following month; otherwise, on the first of the month after next. For hand-signed documents in WRITTEN FORM, the complete, filled-out and signed documents must be sent in advance as a scan to the email address [email protected] or via the communication section in the tender portal www.dtvp.de in a timely manner, if the complete and correct original documents in paper form are received by AOK Bayern, Vergabestelle, by the 10th of the month. Please note the completion instructions, which are available under www.dtvp.de with the tender documents. Interested pharmaceutical companies can request the release of the tender documents in the project room for the open-house procedure on the portal www.dtvp.de. A link to the portal is included in this notice. Only pharmaceutical companies are considered potential contractual partners. The documents of the open-house procedure will only be released to pharmaceutical companies as potential contractual partners and must be treated as strictly confidential. By requesting the release, the companies confirm the confidential treatment of the documents.